Statements (11)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:developedBy |
Rhizen Pharmaceuticals
|
| https://www.w3.org/2000/01/rdf-schema#label |
RP-6306
|
| gptkbp:intendedUse |
gptkb:cancer
|
| gptkbp:mechanismOfAction |
CDC7 kinase inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:target |
CDC7
|
| gptkbp:bfsParent |
gptkb:Repare_Therapeutics
|
| gptkbp:bfsLayer |
7
|